Alcon Aandeel

Alcon Rule of 40

De Rule of 40 van Alcon (ALC.SW) per 20 aug 2026 bedraagt 23,01 %. In het voorgaande jaar bedroeg Rule of 40 19,08 % — een verandering van 20,61% (hoger).

Rule of 40

23,01 %

YoY

20,61%

Laatst bijgewerkt:

Rule of 40 van Alcon is 2026 23,01 % . Rule of 40 van Alcon was 2025 19,08 % . Het is daarmee 20,61% hoger lager dan het jaar ervoor.
Access this data via the Eulerpool API

Alcon Aandelenanalyse

Wat doet Alcon? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon is een van de meest populaire bedrijven op Eulerpool.

Veelgestelde vragen over het aandeel Alcon

Rule of 40 van Alcon bedraagt 23,01 % in 2026.

Op Eulerpool vindt u de volledige historische ontwikkeling van Rule of 40 Alcon sinds 2006 – met jaarlijkse waarden, grafieken en gedetailleerde analyse.

De Rule of 40 stelt dat het omzetgroeipercentage van een bedrijf plus winstmarge 40% moet overschrijden. Het wordt veel gebruikt om SaaS- en snelgroeiende bedrijven te evalueren.

Access this data via the Eulerpool API

Kwaliteit — Alcon

Alle kengetallen — Alcon